Matthew Blatnik

1.4k total citations
17 papers, 893 citations indexed

About

Matthew Blatnik is a scholar working on Physiology, Molecular Biology and Clinical Biochemistry. According to data from OpenAlex, Matthew Blatnik has authored 17 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 8 papers in Molecular Biology and 5 papers in Clinical Biochemistry. Recurrent topics in Matthew Blatnik's work include Metabolomics and Mass Spectrometry Studies (5 papers), Adipose Tissue and Metabolism (4 papers) and Advanced Glycation End Products research (4 papers). Matthew Blatnik is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (5 papers), Adipose Tissue and Metabolism (4 papers) and Advanced Glycation End Products research (4 papers). Matthew Blatnik collaborates with scholars based in United States, Chile and Germany. Matthew Blatnik's co-authors include John Baynes, Suzanne R. Thorpe, Norma Frizzell, Mary E. Lame, Erin Chambers, Catherine Soderstrom, Michael D. Walla, Ryoji Nagai, James A. Carson and Yuping Wang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Matthew Blatnik

17 papers receiving 885 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew Blatnik United States	12	462	254	164	159	117	17	893
Anne‐Laure Guihot France	20	456 1.0×	219 0.9×	215 1.3×	56 0.4×	82 0.7×	38	1.1k
Erkan Tuncay Türkiye	20	639 1.4×	183 0.7×	174 1.1×	75 0.5×	51 0.4×	66	1.2k
Jeremiah Stitham United States	22	501 1.1×	152 0.6×	115 0.7×	174 1.1×	71 0.6×	33	1.2k
Colin T. Shearn United States	24	748 1.6×	242 1.0×	144 0.9×	483 3.0×	120 1.0×	59	1.5k
Daoguang Yan China	11	456 1.0×	134 0.5×	146 0.9×	127 0.8×	120 1.0×	13	898
Ola J. Martin United States	10	862 1.9×	578 2.3×	240 1.5×	130 0.8×	55 0.5×	11	1.5k
Kazi N. Islam United States	14	343 0.7×	329 1.3×	163 1.0×	82 0.5×	45 0.4×	48	1.2k
Yael Riahi Israel	19	473 1.0×	287 1.1×	214 1.3×	250 1.6×	63 0.5×	23	1.2k
Rebecca L. Charles United Kingdom	12	620 1.3×	478 1.9×	88 0.5×	47 0.3×	43 0.4×	21	1.2k

Countries citing papers authored by Matthew Blatnik

Since Specialization

Citations

This map shows the geographic impact of Matthew Blatnik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Blatnik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Blatnik more than expected).

Fields of papers citing papers by Matthew Blatnik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Blatnik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Blatnik. The network helps show where Matthew Blatnik may publish in the future.

Co-authorship network of co-authors of Matthew Blatnik

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Blatnik. A scholar is included among the top collaborators of Matthew Blatnik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Blatnik. Matthew Blatnik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Martinꝉ, Roland, Jean‐Baptiste Telliez, Susan Pleasic‐Williams, et al.. (2023). Target Occupancy and Functional Inhibition of JAK3 and TEC Family Kinases by Ritlecitinib in Healthy Adults: An Open‐Label, Phase 1 Study. The Journal of Clinical Pharmacology. 64(1). 67–79. 4 indexed citations

Mi, Michael, Mark Whitlock, Xu Shi, et al.. (2023). Mixed meal tolerance testing highlights in diabetes altered branched-chain ketoacid metabolism and pathways associated with all-cause mortality. American Journal of Clinical Nutrition. 117(3). 529–539. 2 indexed citations

Esquejo, Ryan M., Bina Albuquerque, Anna Sher, et al.. (2022). AMPK activation is sufficient to increase skeletal muscle glucose uptake and glycogen synthesis but is not required for contraction-mediated increases in glucose metabolism. Heliyon. 8(10). e11091–e11091. 9 indexed citations

Miller, Russell, Wenyun Lu, David Pirman, et al.. (2018). Targeting hepatic glutaminase activity to ameliorate hyperglycemia. Nature Medicine. 24(4). 518–524. 54 indexed citations

Meissen, John K., David Pirman, Min Wan, et al.. (2016). Phenotyping hepatocellular metabolism using uniformly labeled carbon-13 molecular probes and LC-HRMS stable isotope tracing. Analytical Biochemistry. 508. 129–137. 6 indexed citations

Kim, Mi-Sung, Sarah A. Krawczyk, Ludivine Doridot, et al.. (2016). ChREBP regulates fructose-induced glucose production independently of insulin signaling. Journal of Clinical Investigation. 126(11). 4372–4386. 162 indexed citations

Zhang, Guodong, Zhaosheng Lin, Xiaogang Han, et al.. (2013). Strategies for quantitation of endogenous adenine nucleotides in human plasma using novel ion-pair hydrophilic interaction chromatography coupled with tandem mass spectrometry. Journal of Chromatography A. 1325. 129–136. 34 indexed citations

Blatnik, Matthew, et al.. (2013). 2-Arachidonoylglycerol is a substrate for butyrylcholinesterase: A potential mechanism for extracellular endocannabinoid regulation. Archives of Biochemistry and Biophysics. 536(1). 1–5. 11 indexed citations

Blatnik, Matthew & Xiaogang Han. (2012). Bioanalysis Young Investigator: Matthew Blatnik. Bioanalysis. 4(12). 1403–1405. 1 indexed citations

10.

Blatnik, Matthew, et al.. (2012). Prandial Ghrelin Attenuation Provides Evidence That Des-Acyl Ghrelin May Be An Artifact of Sample Handling in Human Plasma. Bioanalysis. 4(20). 2447–2455. 17 indexed citations

11.

Lame, Mary E., Erin Chambers, & Matthew Blatnik. (2011). Quantitation of amyloid beta peptides Aβ1–38, Aβ1–40, and Aβ1–42 in human cerebrospinal fluid by ultra-performance liquid chromatography–tandem mass spectrometry. Analytical Biochemistry. 419(2). 133–139. 95 indexed citations

12.

Blatnik, Matthew & Rick C. Steenwyk. (2010). Quantification of urinary PGEm, 6-keto PGF1α and 2,3-dinor-6-keto PGF1α by UFLC–MS/MS before and after exercise. Prostaglandins & Other Lipid Mediators. 93(1-2). 8–13. 12 indexed citations

13.

Blatnik, Matthew & Catherine Soderstrom. (2010). A practical guide for the stabilization of acylghrelin in human blood collections. Clinical Endocrinology. 74(3). 325–331. 46 indexed citations

14.

Blatnik, Matthew, Suzanne R. Thorpe, & John Baynes. (2008). Succination of Proteins by Fumarate. Annals of the New York Academy of Sciences. 1126(1). 272–275. 78 indexed citations

15.

Nagai, Ryoji, Jonathan W. C. Brock, Matthew Blatnik, et al.. (2007). Succination of Protein Thiols during Adipocyte Maturation. Journal of Biological Chemistry. 282(47). 34219–34228. 95 indexed citations

16.

Blatnik, Matthew, Norma Frizzell, Suzanne R. Thorpe, & John Baynes. (2007). Inactivation of Glyceraldehyde-3-Phosphate Dehydrogenase by Fumarate in Diabetes. Diabetes. 57(1). 41–49. 114 indexed citations

17.

Alderson, Nathan L., Yuping Wang, Matthew Blatnik, et al.. (2006). S-(2-Succinyl)cysteine: A novel chemical modification of tissue proteins by a Krebs cycle intermediate. Archives of Biochemistry and Biophysics. 450(1). 1–8. 153 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact